Publication | Closed Access

A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis

RheumatologySystemic TreatmentClinical TrialsCutaneous SarcoidosisClinical DermatologyPlacebo-controlled TrialPharmacotherapyDermatologyMedicineRheumatoid Arthritis